DrugJul 8, 2026
TERPENICOL Antifungal Solution recall — FDA D-0697-2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class IIFDA: OngoingBlaine Labs Inc
Recall history in this database
Classification mix: Class II: 7, Class I: 1.
DrugJul 8, 2026
Blaine Labs Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit recall — FDA D-0698-2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class IIFDA: OngoingBlaine Labs Inc
DrugJul 8, 2026
Blaine Labs Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1% recall — FDA D-0692-2026
Microbial contamination of Non-Sterile Product: samples identified the presence of Lysinibacillus fusiformis and other Bacillus spp
Class IFDA: OngoingBlaine Labs Inc
DrugJul 8, 2026
TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle recall — FDA D-0694-2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class IIFDA: OngoingBlaine Labs Inc
DrugJul 8, 2026
Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) recall — FDA D-0699-2026
CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated
Class IIFDA: OngoingBlaine Labs Inc
DrugJul 8, 2026
Blaine Labs vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle recall — FDA D-0696-2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class IIFDA: OngoingBlaine Labs Inc
DrugJul 8, 2026
TRIDERGEL TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recall — FDA D-0693-2026
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
Class IIFDA: OngoingBlaine Labs Inc
DrugJul 8, 2026
TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles recall — FDA D-0695-2026
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Class IIFDA: OngoingBlaine Labs Inc
Understanding this recall history
This page summarizes recall records in which the official source identifies Blaine Labs Inc as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.